1. Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancer 
Raja Flores, MD, Thomas Bauer, MD, Ralph Aye, MD, Shahriyour Andaz, MD, Leslie Kohman, MD, Barry Sheppard, MD, William Mayfield, MD, Richard Thurer, MD, Michael Smith, MD, Robert Korst, MD, Michaela Straznicka, MD, Fred Grannis, MD, Harvey Pass, MD, Cliff Connery, MD, Rowena Yip, MPH, James P. Smith, MD, David Yankelevitz, MD, Claudia Henschke, PhD, MD, Nasser Altorki, MD 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 147, Issue 5, Pages (May 2014)
DOI: /j.jtcvs
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

2. Figure 1
Kaplan-Meier lung cancer–specific survival for all patients who underwent resection, separately for all stages and for all clinical stage I cases resected within 1 month of diagnosis. Typical carcinoids were excluded. CI, Confidence interval.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

3. Figure 2
Kaplan-Meier lung cancer–specific survival curve for all patients diagnosed as pathologic stage I by tumor diameter of the pathology specimen. Typical carcinoids were excluded. CI, Confidence interval.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs )
Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions